Viveve
ProfileJobs

Viveve

Suggest Edit
    • Healthclinicsmedical deviceswomen's health
    Viveve, Inc., the wholly owned subsidiary of Viveve Medical, Inc., is a women's health and wellness company. It is focused on the commercialization of a revolutionary, non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue. The Viveve System incorporates clinically-proven, cryogen-cooled, monopolar radiofrequency (CMRF) energy to uniformly deliver deep- penetrating volumetric heat while gently cooling surface tissue to treat the condition of vaginal laxity.
    Revenue(FY, 2017)
    $15.3 M
    Market capitalization(2018-05-25)
    $76 M
    Type
    Public
    HQ
    Sunnyvale, US
    Founded
    2005
    Size (employees)
    42 (est)
    Website
    viveve.com
    Viveve was founded in 2005 and is headquartered in Sunnyvale, US
    Report incorrect company information

    Viveve Office Locations

    Viveve has an office in Sunnyvale
    Sunnyvale, US (HQ)
    150 Commercial St
    Show all (1)
    Report incorrect company information

    Viveve Financials and Metrics

    Viveve Financials

    Viveve's revenue was reported to be $15.29 m in FY, 2017
    USD

    Revenue (Q1, 2018)

    		3.7 m

    Gross profit (Q1, 2018)

    		1.3 m

    Gross profit margin (Q1, 2018), %

    		36.4%

    EBIT (Q1, 2018)

    		(11.3 m)

    Market capitalization (25-May-2018)

    		76 m

    Closing share price (25-May-2018)

    		2.4

    Cash (31-Mar-2018)

    		38.4 m
    Viveve's current market capitalization is $76 m.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Revenue

    		1.3 m90 k1.4 m7.1 m15.3 m

    Revenue growth, %

    		(93%)1508%394%

    Cost of goods sold

    		531 k50 k985 k4.6 m7.8 m

    Gross profit

    		743 k40 k462 k2.5 m7.4 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

    Revenue

    		348 k54 k73 k17.2 k38 k73 k584 k1.3 m1.6 m1.8 m3 m3.1 m3.7 m

    Cost of goods sold

    		124 k31 k24 k14.7 k50 k53 k417 k936 k1 m1.2 m1.6 m1.8 m2.4 m

    Gross profit

    		224 k23 k49 k2.5 k(12 k)20 k167 k348 k534 k691 k1.4 m1.2 m1.3 m

    Gross profit Margin, %

    		64%43%67%14%(32%)27%29%27%34%37%47%40%36%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		769 k895 k7.4 m8.1 m20.7 m

    Accounts Receivable

    		6 k593 k2.1 m

    Inventories

    		117 k923 k1.6 m2.7 m2.4 m

    Current Assets

    		1.5 m2 m11.1 m13.9 m32.1 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

    Cash

    		1.4 m128 k87 k2 m221 k8.4 m6.1 m5 m19.9 m14 m31.4 m31.1 m38.4 m

    Accounts Receivable

    		3.8 k35 k6 k239 k791 k589 k1.8 m4 m3.8 m

    Inventories

    		145 k112 k101 k136.9 k167 k337 k645 k926 k845 k1.4 m2.4 m2 m3.8 m

    Current Assets

    		2.4 m576 k704 k2.3 m1.3 m10.4 m8.6 m8.3 m22.6 m18.5 m39 m38.8 m52.5 m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		3.5 m(6.2 m)(12.4 m)(20.1 m)(37 m)

    Depreciation and Amortization

    		53 k56 k77 k111 k449 k

    Inventories

    		42 k(41 k)(879 k)(1.2 m)(67 k)

    Accounts Payable

    		48 k(551 k)1 m1.7 m1.7 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

    Net Income

    		(609 k)(2.4 m)2.3 m(2.5 m)(2.5 m)(3 m)(3.2 m)(12.7 m)

    Depreciation and Amortization

    		150 k

    Inventories

    		101 k136.9 k167 k337 k645 k926 k845 k1.4 m2.4 m(1.5 m)

    Accounts Payable

    		775 k566.1 k612 k612 k1.1 m1.6 m1.9 m2.5 m3.4 m(934 k)
    show all
    USDY, 2018

    Financial Leverage

    		3 x
    Show all financial metrics
    Report incorrect company information

    Competitors

    Veru
    Health - Public
    Pulmonx
    Health - Private
    Utah Medical Products
    Health - Public
    Chiaro Technology
    Health - Private
    Compare competitors

    Viveve News and Updates

    May 10, 2018

    Viveve Medical's (VIVE) CEO Scott Durbin on Q1 2018 Results - Earnings Call Transcript

    December 19, 2017

    Middle East and North Africa (MENA) Medical Aesthetic Devices Market is Expected to Represent US$755.8 mn by 2024

    Middle East and North Africa (MENA) Medical Aesthetic Devices Market: Increasing Aesthetic Consciousness among Consumers to Boost Growth, says TMR Posted via Industry Today. Follow us on Twitter @IndustryToday
    Report incorrect company information
    Download PDF